Abstract
Acute leukemia is the most common cancer in children but without definable causes in the majority of cases. Most cases are pre-B cell in origin, and this immunophenotype has increased in incidence over the past several decades in the Western world. Variable epidemiologic associations have been discovered between chemical exposures and childhood leukemia including parental smoking, pesticides, traffic fumes, and diet. However, much of the increase in leukemia rates is likely linked to changing patterns of infection during early childhood development. New evidence suggests that children who contract leukemia may harbor a congenital defect in immune responder status, as indicated by lower levels of constitutive neonatal IL-10 levels at birth. Medical record studies also demonstrate that childhood ALL patients received clinical care for infections within the first year of life despite having lower levels of exposure to infections.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, Le Beau MM, Beran M, Tallman MS, Ebert BL, Kantarjian HM, Stone RM, Gilliland DG, Crispino JD, Levine RL (2009) Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114(1):144–147
Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhaes IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61(6):2542–2546
Aplan PD, Chervinsky DS, Stanulla M, Burhans WC (1996) Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors [see comments]. Blood 87(7):2649–2658
Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30(1):41–47
Bernsen RM, de Jongste JC, van der Wouden JC (2003) Birth order and sibship size as independent risk factors for asthma, allergy, and eczema. Pediatr Allergy Immunol 14(6):464–469
Bowen DT (2006) Etiology of acute myeloid leukemia in the elderly. Semin Hematol 43(2):82–88
Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le N, Rowley JD (1996) Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87(5):1912–1922
Burmeister T, Meyer C, Schwartz S, Hofmann J, Molkentin M, Kowarz E, Schneider B, Raff T, Reinhardt R, Gokbuget N, Hoelzer D, Thiel E, Marschalek R (2009) The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group. Blood 113(17):4011–4015
Cardwell CR, McKinney PA, Patterson CC, Murray LJ (2008) Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records. Br J Cancer 99(9):1529–1533
Chang JS (2009) Parental smoking and childhood leukemia. Methods Mol Biol 472:103–137
Chang P, Kang M, Xiao A, Chang J, Feusner J, Buffler P, Wiemels J (2010) FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia. BMC Cancer 10:513
Chang JS, Tsai C-R, Wiemels JL (2011a) Allergy and risk of childhood leukemia: a population-based and record based study. North American Congress of Epidemiology, Montreal, Canada
Chang JS, Zhou M, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL (2011b) Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 20(8):1736–1740
Chow EJ, Puumala SE, Mueller BA, Carozza SE, Fox EE, Horel S, Johnson KJ, McLaughlin CC, Reynolds P, Von Behren J, Spector LG (2010) Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis. Cancer 116(12):3045–3053
Cimino G, Rapanotti MC, Biondi A, Elia L, Lo Coco F, Price C, Rossi V, Rivolta A, Canaani E, Croce CM, Mandelli F, Greaves M (1997) Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res 57(14):2879–2883
Dickinson HO, Parker L (1999) Quantifying the effect of population mixing on childhood leukaemia risk: the Seascale cluster [see comments]. Br J Cancer 81(1):144–151
Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ (2001) Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 30(6):1428–1437
Fasching K, Panzer S, Haas OA, Borkhardt A, Marschalek R, Griesinger F, Panzer-Grumayer ER (2001) Presence of N regions in the clonotypic DJ rearrangements of the immunoglobulin heavy-chain genes indicates an exquisitely short latency in t(4;11)-positive infant acute lymphoblastic leukemia. Blood 98(7):2272–2274
Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Rebbeck TR, Nowell PC, Lange BJ (1998) MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children. J Pediatr Hematol Oncol 20(4):299–308
Francis SS, Selvin S, Yang W, Buffler PA, Wiemels JL (2011) Unusual space-time patterning of the Fallon, Nevada leukemia cluster: evidence of an infectious etiology. Chem Biol Interact. http://www.ncbi.nlm.nih.gov/pubmed?term=francis%20wiemels# [Epub ahead of print]
Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves MF (1997) Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94(25):13950–13954
Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti AB (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23(3):577–589
Greaves MF (1988) Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 2(2):120–125
Greaves MF (1997) Aetiology of acute leukaemia. Lancet 349(9048):344–349
Greaves M (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6(3):193–203
Greaves MF, Alexander FE (1993) An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 7(3):349–360
Groves F, Auvinen A, Hakulinen T (2000) Haemophilus influenzae type b vaccination and risk of childhood leukemia in a vaccine trial in finland. Ann Epidemiol 10(7):474
Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the U.S. Cancer 78(3):532–541
Haby MM, Marks GB, Peat JK, Leeder SR (2000) Daycare attendance before the age of two protects against atopy in preschool age children. Pediatr Pulmonol 30(5):377–384
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Hayes RB, Yin S, Rothman N, Dosemeci M, Li G, Travis LT, Smith MT, Linet MS (2000) Benzene and lymphohematopoietic malignancies in China. J Toxicol Environ Health A 61(5–6):419–432
Jung R, Jacobs U, Krumbholz M, Langer T, Keller T, De Lorenzo P, Valsecchi MG, van der Velden VH, Moericke A, Stanulla M, Teigler-Schlegel A, Panzer-Gruemayer ER, van Dongen JJ, Schrappe M, den Boer ML, Pieters R, Rascher W, Metzler M (2010) Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment. Leukemia 24(4):903–907
Kaatsch P, Mergenthaler A (2008) Incidence, time trends and regional variation of childhood leukaemia in Germany and Europe. Radiat Prot Dosimetry 132(2):107–113
Kim-Rouille MH, MacGregor A, Wiedemann LM, Greaves MF, Navarrete C (1999) MLL-AF4 gene fusions in normal newborns [letter; comment]. Blood 93(3):1107–1108
Kinlen L (1988) Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 2(8624):1323–1327
Kinlen LJ (1995) Epidemiological evidence for an infective basis in childhood leukaemia [editorial]. Br J Cancer 71(1):1–5
Kramer U, Heinrich J, Wjst M, Wichmann HE (1999) Age of entry to day nursery and allergy in later childhood. Lancet 353(9151):450–454
Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2004) Hematotoxicity in workers exposed to low levels of benzene. Science 306(5702):1774–1776
Langemeijer SM, Aslanyan MG, Jansen JH (2009) TET proteins in malignant hematopoiesis. Cell Cycle 8(24):4044–4048
Larson RA, Le Beau MM, Ratain MJ, Rowley JD (1992) Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia [letter]. Blood 79(7):1892–1893
Larson RA, LeBeau MM, Vardiman JW, Rowley JD (1996) Myeloid leukemia after hematotoxins. Environ Health Perspect 104(suppl 6):1303–1307
Lewis SA, Britton JR (1998) Consistent effects of high socioeconomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood. Respir Med 92(10):1237–1244
Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 112(2):416–432
Linabery AM, Jurek AM, Duval S, Ross JA (2010) The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol 171(7):749–764
Little MP (2008) Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups. Radiat Prot Dosimetry 132(2):156–165
Liu XP, Zhu XF, Wang JX, Mi YC, Zou Y, Chen YM, Li CW, Dai Y, Qin S, Xiao JG, Xu FY, Gong JY, Wang SP, Yu CL, Fan J (2009) A comparative cytogenetic analysis in large scale between adult and childhood patients with acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(6):1399–1404
Ma X, Does MB, Metayer C, Russo C, Wong A, Buffler PA (2005) Vaccination history and risk of childhood leukaemia. Int J Epidemiol 34(5):1100–1109
Maia AT, Koechling J, Corbett R, Metzler M, Wiemels JL, Greaves M (2004) Protracted postnatal natural histories in childhood leukemia. Genes Chromosomes Cancer 39(4):335–340
McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Feusner J, Matthay K, Dahl G, Smith MT (2003a) Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Blood 101(11):4640–4641
McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Guo W, Loh ML, Smith MT (2003b) Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 37(1):36–43
Medinsky MA, Kenyon EM, Schlosser PM (1995) Benzene: a case study in parent chemical and metabolite interactions. Toxicology 105(2–3):225–233
Metayer C, Buffler PA (2008) Residential exposures to pesticides and childhood leukaemia. Radiat Prot Dosimetry 132(2):212–219
Metzgar D, Osuna M, Kajon AE, Hawksworth AW, Irvine M, Russell KL (2007) Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 196(10):1465–1473
Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, Hows JM, Navarrete C, Greaves M (2002) Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 99(12):8242–8247
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572–1582
Ognjanovic S, Blair C, Spector LG, Robison LL, Roesler M, Ross JA (2011) Analgesic use during pregnancy and risk of infant leukaemia: a Children’s Oncology Group study. Br J Cancer 104(3):532–536
Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, Houlston RS (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006–1010
Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr (1998) Cancer statistics by race and ethnicity. CA Cancer J Clin 48(1):31–48
Pombo-de-Oliveira MS, Koifman S (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 15(12):2336–2341
Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, Sheridan E, Gast A, Kinsey SE, Lightfoot T, Roman E, Taylor M, Pritchard-Jones K, Stanulla M, Schrappe M, Bartram CR, Houlston RS, Kumar R, Hemminki K (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 115(9):1765–1767
Pui CH, Carroll WL, Meshinchi S, Arceci RJ (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 29(5):551–565
Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (1999) Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995. NIH Pub. 99-4649. National Cancer Institute, Bethesda
Roman E, Simpson J, Ansell P, Kinsey S, Mitchell CD, McKinney PA, Birch JM, Greaves M, Eden T (2007) Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 165(5):496–504
Ross JA, Potter JD, Robison LL (1994) Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 86(22):1678–1680
Roulston D, Espinosa R III, Nucifora G, Larson RA, Le Beau MM, Rowley JD (1998) CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92(8):2879–2885
Rowley JD, Olney HJ (2002) International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer 33(4):331–345
Russell KL, Broderick MP, Franklin SE, Blyn LB, Freed NE, Moradi E, Ecker DJ, Kammerer PE, Osuna MA, Kajon AE, Morn CB, Ryan MA (2006) Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J Infect Dis 194(7):877–885
Scelo G, Metayer C, Zhang L, Wiemels JL, Aldrich M, Selvin S, DuCore J, Smith MT, Buffler PA (2008) Home use of paint and petroleum solvents before birth and early childhood and risk of childhood leukemia. Environ Health Perspect. 2009 Jan;117(1):133-9.
Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J (2003) Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 105(2):255–260
Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, Gast A, Dobbins SE, Ma Y, Sheridan E, Taylor M, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Moorman AV, Harrison CJ, Tomlinson IP, Richards S, Zimmermann M, Szalai C, Semsei AF, Erdelyi DJ, Krajinovic M, Sinnett D, Healy J, Gonzalez A, Kawamata Neira N, Ogawa S, Koeffler HP, Hemminki K, Greaves M, Houlston RS (2010) Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 42(6):492–494
Sim SP, Liu LF (2001) Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J Biol Chem 276(34):31590–31595
Simpson J, Smith A, Ansell P, Roman E (2007) Childhood leukaemia and infectious exposure: a report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer 43(16):2396–2403
Slater ME, Linabery AM, Spector LG, Johnson KJ, Hilden JM, Heerema NA, Robison LL, Ross JA (2011) Maternal exposure to household chemicals and risk of infant leukemia: a report from the Children’s Oncology Group. Cancer Causes Control 22(8):1197–1204
Smith MT (1996) The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect 104(suppl 6):1219–1225
Spector L, Groves F, DeStefano F, Liff J, Klein M, Mullooly J, Black S, Shinefield H, Ward J, Marcy M (2004) Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer 40(4):579–584
Steenbergen EJ, Verhagen OJ, van Leeuwen EF, Behrendt H, Merle PA, Wester MR, von dem Borne AE, van der Schoot CE (1994) B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Eur J Immunol 24(4):900–908
Steinmaus C, Smith AH, Jones RM, Smith MT (2008) Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med 65(6):371–378
Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299(6710):1259–1260
Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD (2000) Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97(9):4790–4795
Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ (1998) An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92(10):3793–3803
Strissel PL, Strick R, Tomek RJ, Roe BA, Rowley JD, Zeleznik-Le NJ (2000) DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 9(11):1671–1679
Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC, Pui CH, Evans WE, Relling MV (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41(9):1001–1005
Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X (2010) A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol 39(3):718–732
Vaughan AT, Betti CJ, Villalobos MJ (2002) Surviving apoptosis. Apoptosis 7(2):173–177
Vijayakrishnan J, Houlston RS (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 95(8):1405–1414
Wasserman R, Galili N, Ito Y, Reichard BA, Shane S, Rovera G (1992) Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event. J Exp Med 176(6):1577–1581
Westergaard T, Andersen PK, Pedersen JB, Olsen JH, Frisch M, Sorensen HT, Wohlfahrt J, Melbye M (1997) Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 89(13):939–947
Westergaard T, Rostgaard K, Wohlfahrt J, Andersen PK, Aaby P, Melbye M (2005) Sibship characteristics and risk of allergic rhinitis and asthma. Am J Epidemiol 162(2):125–132
Wiemels J (2008) Chromosomal translocations in childhood leukemia: natural history, mechanisms, and epidemiology. J Natl Cancer Inst Monogr 39:87–90
Wiemels J, Wiencke JK, Varykoni A, Smith MT (1999a) Modulation of the toxicity and macromolecular binding of benzene metabolites by NAD(P)H: quinone oxidoreductase in transfected HL-60 cells. Chem Res Toxicol 12(6):467–475
Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, Saha V, Biondi A, Greaves MF (1999b) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354(9189):1499–1503
Wiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, Smith MT, Crouse V, Ma X, Buffler PA, Pine SR (2002a) Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 99(23):15101–15106
Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, Smith MT, Zhang L, Feusner J, Wiencke J, Pritchard-Jones K, Kempski H, Greaves M (2002b) In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 99(10):3801–3805
Wiemels JL, Kang M, Chang JS, Zheng L, Kouyoumji C, Zhang L, Smith MT, Scelo G, Metayer C, Buffler P, Wiencke JK (2010) Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia. Blood Cells Mol Dis 45(3):186–191
Zhang L, Rothman N, Wang Y, Hayes RB, Li G, Dosemeci M, Yin S, Kolachana P, Titenko-Holland N, Smith MT (1998) Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis 19(11):1955–1961
Zhang G, Rowe J, Kusel M, Bosco A, McKenna K, de Klerk N, Sly PD, Holt PG (2009) Interleukin-10/interleukin-5 responses at birth predict risk for respiratory infections in children with atopic family history. Am J Respir Crit Care Med 179(3):205–211
Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M, Buetow KH, Carroll WL, Chen IM, Devidas M, Gerhard DS, Loh ML, Reaman GH, Relling MV, Camitta BM, Bowman WP, Smith MA, Willman CL, Downing JR, Hunger SP (2011a) Key pathways are frequently mutated in high risk childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood 118(11):3080–3087
Zhang L, Lan Q, Guo W, Hubbard AE, Li G, Rappaport SM, McHale CM, Shen M, Ji Z, Vermeulen R, Yin S, Rothman N, Smith MT (2011b) Chromosome-wide aneuploidy study (CWAS) in workers exposed to an established leukemogen, benzene. Carcinogenesis 32(4):605–612
Zuna J, Madzo J, Krejci O, Zemanova Z, Kalinova M, Muzikova K, Zapotocky M, Starkova J, Hrusak O, Horak J, Trka J (2011) ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia. Blood 117(1):368–369; author reply 370–371
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wiemels, J. (2012). Childhood Acute Leukemia. In: Dietert, R., Luebke, R. (eds) Immunotoxicity, Immune Dysfunction, and Chronic Disease. Molecular and Integrative Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-812-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-812-2_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-811-5
Online ISBN: 978-1-61779-812-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)